IRINA KOGAN: Open Payments
NPI 1316352271 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 16 payments from 8 companies in 2025. Trend: 2023 $299 · 2024 $303 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $106 |
| UCB, Inc. | 4 | $95 |
| E.R. Squibb & Sons, L.L.C. | 2 | $61 |
| Indivior Inc. | 2 | $44 |
| ABBVIE INC. | 1 | $30 |
| Eisai Inc. | 1 | $23 |
| Biogen, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: ARISTADA, Briviact, COBENFY, SUBLOCADE, VRAYLAR, Leqembi, VUMERITY, CAPLYTA.
Industry payments across NY — which companies pay providers there.
